Neurocrine Biosciences: Q3 Earnings Insights


Neurocrine Biosciences NBIX reported its Q3 earnings results on Tuesday, November 1, 2022 at 07:30 AM.

Here's what investors need to know about the announcement.


Neurocrine Biosciences beat estimated earnings by 35.0%, reporting an EPS of $1.08 versus an estimate of $0.8.

Revenue was up $91.90 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.25 which was followed by a 8.45% increase in the share price the next day.

Here's a look at Neurocrine Biosciences's past performance:


Quarter Q2 2022 Q1 2022 Q4 2021 Q3 2021
EPS Estimate 0.59 0.34 0.52 0.60
EPS Actual 0.84 0.30 0.04 0.64
Revenue Estimate 341.31M 303.40M 316.79M 297.65M
Revenue Actual 378.20M 310.60M 312.00M 296.00M

To track all earnings releases for Neurocrine Biosciences visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!